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Abstract: Dysmenorrhea is common gynecological problem among women. This study was done to examine the 
effects omega-3 fatty acid compared to ibuprofen on dysmenorrhea. A double- blind crossover study was conducted 
among 18-22 years old female student. Women assigned to group 1 received 2 omega-3 capsules daily in the 
morning and night after food for 2 month and group 2 receive 400 mg ibuprofen very 8 hours in three days. It was a 
one month washout period. Then each group received drug other group. Data were gathered the start, after 8  and 20 
weeks by using the Cox Menstrual Symptom Scale questionare. Data were analyzed using spss 16.0 via Paired t- test 
and Repeated Measurement. The mean age of students was 20.35 ± 1.03 years and their mean BMI was 21.03 ± 2.40 
kg /m2. Result showed a marked reduction in pain intensity after treatment with omega-3(P<0.05). Also our results 
indicate that in the first day(P=0.28), the second day(P=0.30)  and the  third day(P=0.67) of  menstruation,  the 
effect  of omega-3 and ibuprofen  was similar. The results indicate that dietary supplementation with omeg-3 fatty 
acid can reduced noticeable pain as ibuprofen among young women with primary dysmenorrhea.  
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1. Introduction 
Dysmenorrhea  is  common gynecological 
problem among women which is divided into two 
categories, primary and secondary. Primary 
dysmenorrheal is  painful menstruation in the absence 
of pelvic disease. The pain of uterine origin is 
associated with symptoms such as nausea, vomiting, 
abdominal distension, diarrhea, headache and rarely 
even myocardial infarction (1,2). 
Prevalence of primary dysmenorrhea in various 
communities should have between 50 to 90% (3,4). 
The prevalence of dysmenorrhea  have been reported 
74-86%  in Iran (4) 
The use of non- steroidal anti- inflammatory 
drugs (NSAIDS) can reduce pain of primary 
dysmenorrhea in women with primary 
dysmenorrhea(5). There fore, adverse side effects 
may occur after long- term use of these drugs. These 
adverse effects are impaired kidney function and 
gastrointestinal bleeding which could limit their use 
in primary dysmenorrheal(6,7). 
Today, various studies dietary supplements have 
been effective for the treatment of dysmenorrhea. 
These supplements are omega-3 fatty acids, 
magnesium, zinc, vitamin B and vitamin E (8). 
Research has shown omega-3 two months can receive 
a blood concentration of this substance to induce 
anti-inflammatory and analgesic effects provided 
(9,10,11,12). Most studies have shown that omega-3 
fatty acids are well tolerated by most people and 
rarely in the high dose (more than 6 grams per day) 
are adverse side effects (13). Omega-3 fatty acids 
possess anti- inflammatory effects due to produce 
vasodilator ecosanoids such as PGE3 and PGF3 and 
inhibit of production vasoconstrictor prostaglandin 
PGE2, PGF2 from omeg-6 which is the important 
cause primary dysmenorrheal(12,14). 
The aim of the study was to evaluate the effects 
of marine omega-3 fatty acids compared to ibuprofen 
on primary dysmenorrehea.  
 
2. Materials and methods 
A double- blind crossover study was conducted 
among 18-22 years old female student at Sabzevar 
university of Medical science. The students had 
primary menstrual pain without significant pathology 
and with regular menstrual cycles. The research 
proposal was approved by the Ethics committee of 
Sabzevar university of Medical science and all 
students signed a consent form. 
The sample size estimation for each group was 
24 at a power of 1-β of 90% and α=0.05% and C.V 
10% and t (0.025,26)=2.056 and t (0.1,26)=1.315 
based on below formula: 
n≥{t(α/2,2n-2+t(β,2n-2)}2  {C.V/10}2  (15). 
After a primary examination, women who had 
inclusion criteria were participated in the present 
study. All student divide to two groups based on table 
of random numbers. 
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Women in group 1 received 2 omega-3 capsule 
(contain of 180 mg of EPA and 120 mg of DHA) 
daily in the morning and night after food for 2 month 
and group 2 receive 400mg ibuprofen a very 8 hours 
in three days.( One day before and two days after 
menstrual period three times in day). It was a one 
month washout period without any medication. Then 
each group received drug other group. 
After the time, Data were gathered before the 
start, after 8 and 20 weeks by using the Cox 
Menstrual Symptom Scale questionnaire (16).In 
addition, the dietary intakes of subjects were assessed 
a 2-days dietary recall at baseline and the end of 
weeks 8 and 20. Subject diets were analyzed by 
Nutrition-IV software.  Data were analyzed using 
SPSS version 16.0 via Paired t- test and Repeated 
Measurement. 
 
3. Results 
of the 50 female student who enrolled, 3 were lost to 
follow- up. The mean age of students and mean age 
of first menorah and dysmenorrhea was shown in 
table 1. 56% of all students in first day, 18% in 
second day and 16% in third day had pain.  
 
Table 1: characteristics of study subjects 
Mean ± SD 
Age (year) 20.35 ± 1.03 
Age first menorah (years) 13.47 ± 2.29 
Age of dysemeorreh (years) 12.26 ± 5.67 
BMI (kg/m2) 21.03 ± 2.40 
 
AS shown in table 2, the mean pain severity 
score was significantly reduced after omega-3 
supplementation among female students (P=0.002). 
Also, our results indicate that in the first day 
(P=0.28), the second day(P=0.30)  and the  third 
day(P=0.67) of  menstruation,  the effect  of omega-3 
and ibuprofen was similar. Anthropometric and 
dietary factors were not significantly different at 
baseline and the end of weeks 8. 
Table 2: Mean ± SD of pain after intake of omega and Ibuprofen 
Omega group Ibuprofen group 
before after before after 
5.89 ± 3.04 7.67 ± 1.49 5.8 ± 2.7 7.7 ±1.52 
P-value: 0.002 P-value: 0.0001 
 
4. Discussion 
In the present study, omega-3 fatty acid 
supplementation was reduced dysmenorrheal in 
female students but this reduction pain was not 
significant comparison ibuprofen. This results of 
study is consistent with findings Dowlatiyan(1). 
Dowlatiyan et al showed that dietary supplementation 
with omega-3 fatty acids significantly decreased 
primary dysmenorrhea. However the present study 
design omega-3 was compared to ibuprofen. Rahbar 
et al showed that dietary supplementation with 
omega-3 fatty acids significantly decreased primary 
dysmenorrhea. However the present study design was 
higher dosage of omega-3 (2 versus 1capsule) and 
included a washout period  and compared to 
ibuprofen  (8). 
In another study, Zamani et al evaluated the 
effect of    dietary supplementation with omega-3 
fatty acids  on primary dysmenorrhea on 84 
adolescents(9). The first group received 1 gram 
omega-3 supplement daily for 2 months and second 
group received placebo in the same time. Results of 
their study showed that omega-3 fatty acids 
supplement significantly reduced intensity and 
duration of pain in adolescent girls. 
Moghadamnia et al showed that omega-3 fatty 
acids significantly decrease abdominal and low-back 
pain  and need for NSAIDs drug in adolescent girls 
with primary dysmenorrheal(17). 
Safari et al assessed the effect of dietary 
supplementation with vitamin E  on primary 
dysmenorrhea on 86 female students based to 
randomized design (18). The first group received 500 
IU vitamin E supplement daily for 2days before and 1 
day after menarche and second group received 250 
mg of mefnamic acid  every 8 hours in the same time. 
Results of their study showed that reduction of pain 
was not significant between two group. In other 
words, vitamin E and mefnamic acid reduced 
dysmenorrhea to a same value. The finding reported 
by Safari are similar to our results quality impact of 
dietary supplement with NSAIDs. 
Finally, Detuch et al assessed the influence 
intake of fish and sea foods and menstrual pain on 
220 women 20-45 years old(19). He found that low 
consumption of fish and sea foods correlated with 
primary dysmenorrheal. The other words, women had 
highest level of intake of fish in their diet, they not 
dysmenorrhea.  
The results of the present study indicate that 
dietary supplementation with omeg-3 fatty acid can 
reduced noticeable pain as ibuprofen among young 
women with primary dysmenorrhea. Nevertheless, 
the use of omega-3 fatty acids could potentially offer 
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for the safe and effective treatment of women with 
dysmenorrheal compared to NASAIDS. 
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